Patrick Hayden

3.6k total citations
53 papers, 996 citations indexed

About

Patrick Hayden is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Patrick Hayden has authored 53 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 26 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Patrick Hayden's work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Patrick Hayden is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Patrick Hayden collaborates with scholars based in Ireland, United States and United Kingdom. Patrick Hayden's co-authors include Kenneth C. Anderson, Constantine S. Mitsiades, Paul G. Richardson, Imelda Coyne, Keith Wheatley, Kathleen M. Scott, Andrea Will, Nikhil C. Munshi, Douglas W. McMillin and Nicholas Mitsiades and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Patrick Hayden

51 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Hayden Ireland 19 558 415 346 144 102 53 996
Seiichi Okabe Japan 18 404 0.7× 417 1.0× 273 0.8× 287 2.0× 67 0.7× 92 969
Laure Vincent France 17 439 0.8× 353 0.9× 179 0.5× 136 0.9× 94 0.9× 58 802
Jens Hasskarl United States 20 587 1.1× 137 0.3× 503 1.5× 75 0.5× 129 1.3× 42 1.2k
Anuhar Chaturvedi Germany 18 665 1.2× 614 1.5× 127 0.4× 251 1.7× 58 0.6× 33 1.1k
C. Vasselon France 11 625 1.1× 420 1.0× 273 0.8× 139 1.0× 102 1.0× 27 964
Siân Rizzo United Kingdom 15 601 1.1× 179 0.4× 301 0.9× 111 0.8× 48 0.5× 25 1.1k
Hind Medyouf Germany 13 526 0.9× 247 0.6× 298 0.9× 108 0.8× 56 0.5× 23 976
Annette Orleth Italy 10 620 1.1× 403 1.0× 196 0.6× 60 0.4× 45 0.4× 14 843
Robert McKinstry United States 13 475 0.9× 145 0.3× 435 1.3× 105 0.7× 54 0.5× 21 971
Frédéric Barabé Canada 20 732 1.3× 416 1.0× 286 0.8× 116 0.8× 40 0.4× 38 1.3k

Countries citing papers authored by Patrick Hayden

Since Specialization
Citations

This map shows the geographic impact of Patrick Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hayden more than expected).

Fields of papers citing papers by Patrick Hayden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hayden. The network helps show where Patrick Hayden may publish in the future.

Co-authorship network of co-authors of Patrick Hayden

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Hayden. A scholar is included among the top collaborators of Patrick Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Hayden. Patrick Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gabriel, Emmanuel, Kathryn T. Chen, Ricardo J. Bello, et al.. (2025). Surgical Oncologists for Sustainability: A Statement from the SSO Surgical Oncologists for Sustainability Committee. Annals of Surgical Oncology. 33(3). 2443–2455.
2.
3.
Gagelmann, Nico, Anna Sureda, Silvia Montoto, et al.. (2022). Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper. The Lancet Haematology. 9(10). e786–e795. 23 indexed citations
4.
5.
Garderet, Laurent, Curly Morris, Meral Beksaç, et al.. (2020). Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT. Biology of Blood and Marrow Transplantation. 26(9). 1559–1566. 4 indexed citations
6.
Brodie, R.R., Stephen E. Langabeer, John Quinn, Máirín E. McMenamin, & Patrick Hayden. (2019). Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis. SHILAP Revista de lepidopterología. 7(12). 2579–2580. 2 indexed citations
7.
Hayden, Patrick, et al.. (2019). An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMT. Current Research in Translational Medicine. 67(3). 79–88. 29 indexed citations
8.
Lehners, Nicola, Patrick Hayden, Hartmut Goldschmidt, & Marc S. Raab. (2016). Management of high-risk Myeloma: an evidence-based review of treatment strategies. Expert Review of Hematology. 9(8). 753–765. 1 indexed citations
9.
Hayden, Patrick, et al.. (2014). The effect of preoperative exercise on postoperative outcome in Abdominal Aortic Aneurysm (AAA) patients: Pilot study.. Kent Academic Repository (University of Kent). 1 indexed citations
10.
Raab, Marc S., Iris Breitkreutz, Simon Anderhub, et al.. (2012). GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo. Cancer Research. 72(20). 5374–5385. 56 indexed citations
11.
McMillin, Douglas W., Jake Delmore, Joseph Negri, et al.. (2011). Molecular and cellular effects of multi‐targeted cyclin‐dependent kinase inhibition in myeloma: biological and clinical implications. British Journal of Haematology. 152(4). 420–432. 24 indexed citations
12.
Browne, Paul, Patrick Hayden, Elisabeth Vandenberghe, et al.. (2010). PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells. British Journal of Cancer. 104(2). 281–289. 27 indexed citations
13.
Ooi, Melissa, Patrick Hayden, Vassiliki Kotoula, et al.. (2009). Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib. Clinical Cancer Research. 15(23). 7153–7160. 53 indexed citations
14.
McMillin, Douglas W., Melissa Ooi, Jake Delmore, et al.. (2009). Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235. Cancer Research. 69(14). 5835–5842. 105 indexed citations
15.
Krawczyk, Janusz, Ronan Swords, Tracy Murphy, et al.. (2009). Clofarabine in the treatment of poor risk acute myeloid leukaemia. Hematological Oncology. 28(3). 118–123. 6 indexed citations
16.
O’Dwyer, Michael, et al.. (2009). Home administration of bortezomib: Making a difference to myeloma patients' lives. European Journal of Oncology Nursing. 14(2). 134–136. 9 indexed citations
17.
Hayden, Patrick, et al.. (2009). Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report. Cases Journal. 2(1). 7456–7456. 5 indexed citations
18.
Mitsiades, Constantine S., Patrick Hayden, Kenneth C. Anderson, & Paul G. Richardson. (2007). From the bench to the bedside: emerging new treatments in multiple myeloma. Best Practice & Research Clinical Haematology. 20(4). 797–816. 59 indexed citations
19.
Hayden, Patrick, Constantine S. Mitsiades, Kenneth C. Anderson, & Paul G. Richardson. (2007). Novel therapies in myeloma. Current Opinion in Hematology. 14(6). 609–615. 15 indexed citations
20.
Hayden, Patrick, Fiona Keogh, Michael Carroll, et al.. (2004). A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplantation. 34(6). 545–556. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiichi Okabe Breakdown of academic impact, for papers by Laure Vincent Breakdown of academic impact, for papers by Jens Hasskarl Breakdown of academic impact, for papers by Anuhar Chaturvedi Breakdown of academic impact, for papers by C. Vasselon Breakdown of academic impact, for papers by Siân Rizzo Breakdown of academic impact, for papers by Hind Medyouf Breakdown of academic impact, for papers by Annette Orleth Breakdown of academic impact, for papers by Robert McKinstry Breakdown of academic impact, for papers by Frédéric Barabé
Rankless by CCL
2026